SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
勤劳胡萝卜
Lv0
0 积分
2024-03-02 加入
最近求助
最近应助
互助留言
Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer
1天前
待确认
Subtyping of advanced lung cancer based on PD-L1 expression, tumor histopathology and mutation burden (EGFR and KRAS): a study from North India
2天前
已完结
Race-Associated Genomic Correlates of Therapeutic Response in African American Patients With Non–Small-Cell Lung Cancer
3天前
已完结
MET alterations and their impact on the future of non-small cell lung cancer (NSCLC) targeted therapies
11天前
已完结
Tislelizumab plus chemotherapy for patients withEGFR-mutated non-squamous non-small cell lung cancer who progressed on EGFR tyrosine kinase inhibitor therapy
1个月前
已完结
EGFR tyrosine kinase inhibitors versus cranial radiation therapy for EGFR mutant non-small cell lung cancer with brain metastases: A systematic review and meta-analysis
1个月前
已完结
Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis
1个月前
已完结
[Chinese Experts Consensus on Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (2020 Version)]
1个月前
已完结
Immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: A systematic review
1个月前
已完结
Update 2020: Management of Non-Small Cell Lung Cancer
1个月前
已完结
没有进行任何应助
感谢,点赞,速度真快
1天前
感谢,点赞,速度真快
3天前
感谢,点赞
11天前
感谢,点赞,速度真快,帮大忙了
1个月前
帮大忙了,么么哒
1个月前
感谢,点赞
1个月前
感谢,点赞,速度真快
1个月前
感谢,帮大忙了,么么哒
1个月前
帮大忙了!Thanks♪(・ω・)ノ
1个月前
感谢,速度真快,帮大忙了
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论